CLS Holdings USA Inc (CLSH)

[traderdogzz]

Cannabis Life Sciences Discusses the Benefits of Medical Marijuana with Uptick Newswire’s Stock Day Podcast and Addresses Its Potential Entry into The Massachusetts Market

GlobeNewswire•September 20, 2018

PHOENIX, Sept. 20, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (CLSH) (CLS Holdings, Inc.), also known as Cannabis Life Sciences, does not want to lose sight of how its product can ultimately help people as they expand their market share. Jeffrey Binder, Chairman and Chief Executive Officer of CLS, tells Stock Day’s Everett Jolly there are many opportunities on the horizon.

“There are a lot of applications for [medical marijuana] where it can be beneficial,” says Binder. He then pointed to the example of Colorado where medical marijuana has been used successfully for years. “People are actually flocking to the state,” he explained.

He and Jolly discussed the stats that indicate opioid addiction, in states with medical marijuana, are actually down. On a more personal note, Binder also highlighted other medical uses.

“One of the reason’s I’m in this business is because my Godchild was diagnosed autistic. With early intervention and a dietary supplement, she has mainstreamed in school. She’ll be 8-years-old.” He added, “I don’t want us in the industry to lose sight of the benefits of medical marijuana.”

Jolly then turned to CLS’s recent letters of intent towards two businesses in Massachusetts; indications they are looking to expand.

“We looked to Massachusetts where there are only 39 medical licenses,” explained Binder. “We believe that there will be a very limited number offered by the state. So, we see that as a great opportunity to garner market share.”

Binder told Jolly that CLS has agreed in principle to loan $5 million to In Good Health, a licensed medical dispensary in Brockton. Along with the loan, CLS will have an option to acquire In Good Health. Also, CLS has also agreed in principle to form an 80/20 joint venture with CannAssist, which CLS will own 80%. CannAssist plans to build out a recreationally licensed cultivation grow facility in Leicester.

To hear more about CLS’ future plans, listen to the podcast here: https://upticknewswire.com/featured-interview-ceo-jeffrey-binder-of-cls-holdings-usa-inc-otcqb-clsh-3/

About CLS Holdings USA, Inc.
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.

CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.

To learn more about CLS go here: https://www.clsholdingsinc.com/about

Contact Information
Corporate:
Chairman and CEO
Jeff Binder
[e-mail]
888-438-9132

About Jeffrey Binder

Prior to founding CLS, Mr. Binder served as founder, Chairman and President of Power 3 Network, Inc., a company that develops websites and back offices for home-based businesses. Mr. Binder has invested in and mentored several start-up and mid-stage companies, through his private holding company, JeMJ Financial Services, Inc., which he formed in 1988. Mr. Binder received his Juris Doctorate from the National Law Center, George Washington University, in 1971, where he received the honor of membership in the Order of The Coif. He also served as a legislative assistant to Adlai Stevenson II, a United States Senator for Illinois, and practiced Law at Sonnenschein Nath & Rosenthal, LLP, Chicago, Illinois for five years.

Forward Looking Statements

The completion of both the In Good Health and CannAssist transactions is subject to the execution of definitive agreements between the parties, the receipt of financing by CLS and the satisfaction of customary conditions.

This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. These forward-looking statements include, but are not limited to, statements relating to whether and when certain acquisitions and other transactions will be completed, the timing and quantity of harvests, the anticipated pricing of products and anticipated license approvals. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "intends," "expects," "plans," "goals," "projects," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance and we cannot guaranty that the proposed transactions described in this press release will occur. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events.